For citations:
Karavayeva T.A., Krupitsky E.M., Barinov A.N., Kolik L.G., Ishchenko K.A., Khacheva K.K. Efficacy and safety of Ranquilon® in the therapy of patients with anxiety associated with neurasthenia and adjustment disorder: results of the double-blind, randomized, placebo-controlled, multicenter phase 3 clinical trial. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2024;58(4-2):78-99. (In Russ.) https://doi.org/10.31363/2313-7053-2024-1047
Email this article 